These trajectories were only found in very high-risk tumours—their clonal diversity and clinical behaviour being consistent with the involvement of initiating events previously associated with genomic instability (TP53 mutation and/or MYC(N) amplification [31, 35, 37]); and the presence of aggressive large-cell/anaplastic histology [11]. This evidence concerns the gene TP53 and neoplasm.